Inpharmatis SIA is based in Latvia. The head office is in Riga. The enterprise operates in the Research and Development in Nanotechnology industry. The company was established on September 30, 2015. Inpharmatis SIA currently employs 2 (2023) people. From the latest financial highlights, Inpharmatis SIA reported a net sales revenue increase of 40.15% in 2024. A growth of 71.3% was recorded in its total assets. The enterprise’s net profit margin increased by 4.4% in 2024.

Headquarters
Gertrudes iela 7
Riga; Riga; Postal Code: 1010

Contact Details: Purchase the Inpharmatis SIA report to view the information.

Basic Information

Total Employees:

Purchase the Inpharmatis SIA report to view the information.

Registered Capital:

Purchase the Inpharmatis SIA report to view the information.

Financial Auditors:

Purchase the Inpharmatis SIA report to view the information.

Incorporation Date:

September 30, 2015

Key Executives

Purchase this report to view the information.

Member of Management Board

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Inpharmatis SIA report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.

Net sales revenue

40.15%▲

Total operating revenue

-4.28%▼

Operating profit (EBIT)

141.16%▲

EBITDA

141.16%▲

Net Profit (Loss) for the Period

72.36%▲

Total Assets

71.3%▲

Total Equity

6.8%▲

Operating Profit Margin (ROS)

13.79%▲

Net Profit Margin

4.4%▲

Return on Equity (ROE)

-3.35%▼

Quick Ratio

0.05%▲

Inpharmatis SIA (Latvia)